BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $100 at Credit Suisse
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $64.63 -2.86%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Join SI Premium – FREE
Credit Suisse analyst Martin Auster lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $100.00 (from $102.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Canaan Inc. (CAN) PT Lowered to $2 at BTIG
- Samsung Engineering Co Ltd. (028050:KS) PT Raised to KRW70,000 at CLSA
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
